The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19
Open accessAbstract
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, neurological symptoms increasingly moved into the focus of interest. In this prospective cohort study, we assessed neurological and cognitive symptoms in hospitalized coronavirus disease-19 (COVID-19) patients and aimed to determine their neuronal correlates. Patients with reverse transcription-PCR-confirmed COVID-19 infection who required inpatient treatment primarily because of non-neurological complications were screened between 20 April 2020 and 12 May 2020. Patients (age > 18 years) were included in our cohort when presenting with at least one new neurological symptom (defined as impaired gustation and/or olfaction, performance < 26 points on a Montreal Cognitive Assessment and/or pathological findings on clinical neurological examination). Patients with ≥2 new symptoms were eligible for further diagnostics using comprehensive neuropsychological tests, cerebral MRI and 18fluorodeoxyglucose (FDG) PET as soon as infectivity was no longer present. Exclusion criteria were: premorbid diagnosis of cognitive impairment, neurodegenerative diseases or intensive care unit treatment. Of 41 COVID-19 inpatients screened, 29 patients (65.2 ± 14.4 years; 38% female) in the subacute stage of disease were included in the register. Most frequently, gustation and olfaction were disturbed in 29/29 and 25/29 patients, respectively. Montreal Cognitive Assessment performance was impaired in 18/26 patients (mean score 21.8/30) with emphasis on frontoparietal cognitive functions. This was confirmed by detailed neuropsychological testing in 15 patients. 18FDG PET revealed pathological results in 10/15 patients with predominant frontoparietal hypometabolism. This pattern was confirmed by comparison with a control sample using voxel-wise principal components analysis, which showed a high correlation (R2 = 0.62) with the Montreal Cognitive Assessment performance. Post-mortem examination of one patient revealed white matter microglia activation but no signs of neuroinflammation. Neocortical dysfunction accompanied by cognitive decline was detected in a relevant fraction of patients with subacute COVID-19 initially requiring inpatient treatment. This is of major rehabilitative and socioeconomic relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668
Li, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,076
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019) · Viruses · doi:10.3390/v12010014 · Cited by 1,048
Outcome of delirium in critically ill patients: systematic review and meta-analysis
Salluh, J. I. F., Wang, H., Schneider, E. B., Nagaraja, N., Yenokyan, G., Damluji, A., Serafim, R. B., & Stevens, R. D. (2015) · BMJ · doi:10.1136/bmj.h2538 · Cited by 1,030
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Neuropathological features of Covid-19
Solomon, I. H., Normandin, E., Bhattacharyya, S., Mukerji, S. S., Keller, K., Ali, A. S., Adams, G., Hornick, J. L., Padera, R. F., & Sabeti, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2019373 · Cited by 815 · cited 1×
“Of note, there were also no signs of hypoxic or haemorrhagic damage as reported by others.(33) Thus, frontoparietal cortical hypometabolism might rather be a sequel of a remote process due to brainstem or white matter pathology than direct cortical damage (e.”
BackgroundChu, H., Chan, J. F.-W., Yuen, T. T.-T., Shuai, H., Yuan, S., Wang, Y., Hu, B., Yip, C. C.-Y., Tsang, J. O.-L., Huang, X., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30004-5 · Cited by 748
"Sniffin' sticks": screening of olfactory performance.
Kobal, G., Hummel, T. R., Sekinger, B., Barz, S., Roscher, S., & Wolf, S. (1996) · PubMed · Cited by 704
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679
The role of peripheral immune cells in the CNS in steady state and disease
Prinz, M., & Priller, J. (2017) · Nature Neuroscience · doi:10.1038/nn.4475 · Cited by 657
Self-citationEANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
Varrone, A., Asenbaum, S., Vander Borght, T., Booij, J., Nobili, F., Någren, K., Darcourt, J., Kapucu, Ö. L., Tatsch, K., Bartenstein, P., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1264-0 · Cited by 544
Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43
Dubé, M., Le Coupanec, A., Wong, A. H. M., Rini, J. M., Desforges, M., & Talbot, P. J. (2018) · Journal of Virology · doi:10.1128/jvi.00404-18 · Cited by 452
Kennedy, C., Des Rosiers, M. H., Jehle, J. W., Reivich, M., Sharpe, F., & Sokoloff, L. (1975) · Science · doi:10.1126/science.1114332 · Cited by 436
Metabolic brain networks in neurodegenerative disorders: a functional imaging approach
Eidelberg, D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.003 · Cited by 393
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
Kanberg, N., Ashton, N. J., Andersson, L.-M., Yilmaz, A., Lindh, M., Nilsson, S., Price, R. W., Blennow, K., Zetterberg, H., & Gisslén, M. (2020) · Neurology · doi:10.1212/wnl.0000000000010111 · Cited by 371
Steroid‐Responsive Encephalitis in Coronavirus Disease 2019
Pilotto, A., Odolini, S., Masciocchi, S., Comelli, A., Volonghi, I., Gazzina, S., Nocivelli, S., Pezzini, A., Focà, E., Caruso, A., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25783 · Cited by 315
COVID-19-associated vasculitis and vasculopathy
Becker, R. C. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02230-4 · Cited by 288
Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism
Semmler, A., Hermann, S., Mormann, F., Weberpals, M., Paxian, S. A., Okulla, T., Schäfers, M., Kummer, M. P., Klockgether, T., & Heneka, M. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-38 · Cited by 282
Sepsis-Associated Encephalopathy: From Delirium to Dementia?
Chung, H.-Y., Wickel, J., Brunkhorst, F. M., & Geis, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030703 · Cited by 215
Hornuss, D., Lange, B., Schröter, N., Rieg, S., Kern, W. V., & Wagner, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.017 · Cited by 196
Self-citationMontreal Cognitive Assessment (MoCA): Concept and Clinical Review
Julayanont, P., & Nasreddine, Z. S. (2017) · Cognitive Screening Instruments · doi:10.1007/978-3-319-44775-9_7 · Cited by 187
Spetsieris, P. G., & Eidelberg, D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.025 · Cited by 180
Romoli, M., Jelčić, I., Bernard‐Valnet, R., Azorín, D. G., Mancinelli, L., Akhvlediani, T., Monaco, S., Taba, P., & Sellner, J. (2020) · European Journal of Neurology · doi:10.1111/ene.14382 · Cited by 116
Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
Ameres, M., Brandstetter, S., Toncheva, A. A., Kabesch, M., Leppert, D., Kühle, J., & Wellmann, S. M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10050-y · Cited by 110
Post-sepsis cognitive impairment and associated risk factors: A systematic review
Calsavara, A. J. C., Junior, V. A. N., Barichello, T., & Teixeira, A. L. (2017) · Australian Critical Care · doi:10.1016/j.aucc.2017.06.001 · Cited by 96
Cognitive Screening Instruments: A Practical Approach
Larner, A. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2452-8 · Cited by 86
2- 18 F-fluoro-2-deoxyglucose positron emission tomography in delirium
Haggstrom, L. R., Nelson, J. A., Wegner, E. A., & Caplan, G. A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17701764 · Cited by 78
Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia
Blazhenets, G., Ma, Y., Sörensen, A., Rücker, G., Schiller, F., Eidelberg, D., Frings, L., & Meyer, P. T. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.219097 · Cited by 74
Self-citationLazar, R. M., Pavol, M. A., Bormann, T., Dwyer, M. G., Kraemer, C., White, R., Zivadinov, R., Wertheimer, J. C., Thöne-Otto, A. I. T., Ravdin, L., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.10.041 · Cited by 31
Self-citationBrown, S. M., Collingridge, D. S., Wilson, E. L., Beesley, S. J., Bose, S., Orme, J. F., Jackson, J. C., & Hopkins, R. O. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201804-233oc · Cited by 23
Cited by
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., Lange, F., Andersson, J. L. R., Griffanti, L., Duff, E., et al. (2022) · Nature · doi:10.1038/s41586-022-04569-5 · Cited by 1,646
Nervous system consequences of COVID-19
Spudich, S., & Nath, A. (2022) · Science · doi:10.1126/science.abm2052 · Cited by 437
Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis
Crivelli, L., Palmer, K., Calandri, I., Guekht, A., Beghi, E., Carroll, W., Frontera, J., García‐Azorín, D., Westenberg, E., Winkler, A. S., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12644 · Cited by 374
“…Cohort ** - ** Poor Méndez et al. 2021 Cohort ** - ** Poor Miskowiak et al. 2021 Cohort *** ** *** Good Hellgren et al. 2021 Cohort *** - ** Poor Hosp et al. 2021 Cohort *** ** ** Good Vannorsdall et al. 2021 Cohort **** - * Poor Yesilkaya et al. 2021 Case report Tolentino, J. C., et al. 2021…”
Morphological, cellular and molecular basis of brain infection in COVID-19 patients
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão-Teles, C., da Silva Zuccoli, G., Reis-de-Oliveira, G., Silva-Costa, L. C., et al. (2020) · doi:10.1101/2020.10.09.20207464 · Cited by 331
Komaroff, A. L., & Lipkin, W. I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1187163 · Cited by 317
Metadata
- Authors
- Hosp, J. A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., Thurow, J., Wagner, D., Waller, C., Niesen, W. D., Frings, L., Urbach, H., Prinz, M., Weiller, C., Schroeter, N., & Meyer, P. T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-04-01
- Volume
- 144
- Issue
- 4
- Pages
- 1263-1276
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3151661477
- Cited by
- 384
- References
- 40
- FWCI
- 34.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.